Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Cyril, Fersing"'
Publikováno v:
Medicina, Vol 60, Iss 7, p 1037 (2024)
A 76-year-old female patient presented with an iodine-refractory papillary thyroid carcinoma (PTC), diagnosed eight years earlier, with several lymph node recurrences requiring successive surgeries. Fluorodeoxyglucose ([18F]FDG) positron emission tom
Externí odkaz:
https://doaj.org/article/0be73e3c89b54e449c4b706ddb3f94d9
Autor:
Céleste Souche, Juliette Fouillet, Léa Rubira, Charlotte Donzé, Emmanuel Deshayes, Cyril Fersing
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 462 (2023)
Bisphosphonates are therapeutic agents that have been used for almost five decades in the treatment of various bone diseases, such as osteoporosis, Paget disease and prevention of osseous complications in cancer patients. In nuclear medicine, simple
Externí odkaz:
https://doaj.org/article/914848f7f151482a8d71e5adec6bf5c5
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1051 (2023)
The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major therapeutic breakthrough in nuclear medicine, particularly since the introduction of 177Lu-radiolabeled somatostatin analogs. These radiopharmaceuticals have especi
Externí odkaz:
https://doaj.org/article/35384b5d6d394af0aad607e3fe005dcc
Autor:
Cyril Fersing, Emmanuel Deshayes, Sarah Langlet, Laurence Calas, Vincent Lisowski, Pierre Olivier Kotzki
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-12 (2021)
Abstract Background The purpose of this work was to design, validate and implement a media-fill test combined with fluorescein (MFT-F) for the specific qualification and training of radiopharmacy operators, in accordance with United States Pharmacope
Externí odkaz:
https://doaj.org/article/6ee7274c664d4375990780d1dd5d98a8
Autor:
Charlotte Donzé, Léa Rubira, Lore Santoro, Pierre Olivier Kotzki, Emmanuel Deshayes, Cyril Fersing
Publikováno v:
Healthcare, Vol 10, Iss 11, p 2247 (2022)
Securing both the patient and radiopharmaceuticals (RPs) circuit is an essential concern in nuclear medicine (NM). These circuits converge at the RP administration phase, a key step in patient management in NM. In a continuous quality improvement app
Externí odkaz:
https://doaj.org/article/e05a510f81814929a440677d8b5bc65f
Autor:
Tristan Martin, Anaïs Moyon, Cyril Fersing, Evan Terrier, Aude Gouillet, Fabienne Giraud, Benjamin Guillet, Philippe Garrigue
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 4, Iss 1, Pp 1-8 (2019)
Abstract Background Many nuclear medicine departments have equipped themselves with automated dispensing systems (ADS) for PET radiopharmaceuticals, in both the operators’ and the patients’ interests. Whether partially or fully automated, to date
Externí odkaz:
https://doaj.org/article/0490ed710ec1486483f447f9b286cce8
Autor:
Marie-Claude Eberlé, Cyril Fersing, Sophie Guillemard, Diana Ilonca, Séverine Guiu, Emmanuel Deshayes
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 934 (2022)
A 48-year-old woman was referred for a bone scan as an assessment of bone metastasis from breast cancer. Surprisingly, two hot spots of lung uptake were present in the left lung without any abnormality on CT slices. No history of pulmonary disease wa
Externí odkaz:
https://doaj.org/article/2580adca6bd8495095b562c3056c6e42
Publikováno v:
Pharmaceuticals, Vol 15, Iss 2, p 234 (2022)
With the development of 68Ga and 177Lu radiochemistry, theranostic approaches in modern nuclear medicine enabling patient-centered personalized medicine applications have been growing in the last decade. In conjunction with the search for new relevan
Externí odkaz:
https://doaj.org/article/bd96e5a1e0c8489d839be92a954b011f
Publikováno v:
Pharmaceuticals, Vol 15, Iss 1, p 35 (2021)
Thienopyrimidines are widely represented in the literature, mainly due to their structural relationship with purine base such as adenine and guanine. This current review presents three isomers—thieno[2,3-d]pyrimidines, thieno[3,2-d]pyrimidines and
Externí odkaz:
https://doaj.org/article/15e31d070e4f48af98af91eaf7f4a749
Autor:
Fanny Mathias, Cyril Fersing
Publikováno v:
Acta Pharmaceutica, Vol 72, Iss 1, Pp 9-34 (2022)
Acta Pharmaceutica
Acta Pharmaceutica, 2021, 72 (1), pp.9-34. ⟨10.2478/acph-2022-0007⟩
Volume 72
Issue 1
Acta Pharmaceutica
Acta Pharmaceutica, 2021, 72 (1), pp.9-34. ⟨10.2478/acph-2022-0007⟩
Volume 72
Issue 1
Numerous new emerging therapies, including oral targeted chemotherapies, have recently entered the therapeutic arsenal against acute myeloid leukemia (AML). The significant shift toward the use of these novel therapeutics, administered either alone o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ad816214f7f2c51e5db1e705e5c392
https://doaj.org/article/a75a0365f24a434498e63f20f2883b84
https://doaj.org/article/a75a0365f24a434498e63f20f2883b84